Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: A 5-year follow-up study

Journal of Clinical Oncology

Volumn 21, Issue 20, 2003, Pages 3867-3874

  van Oostrom, Iris ^a   Meijers Heijboer, Hanne ^a   Lodder, Litanja N ^a   Duivenvoorden, Hugo J ^a   van Gool, Arthur R ^a   Seynaeve, Caroline ^a   Van Der Meer, Conny A ^a   Klijn, Jan G M ^a   Van Geel, Bert N ^a   Burger, Curt W ^a   Wladimiroff, Juriy W ^a   Tibben, Aad ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ANXIETY; ARTICLE; BODY IMAGE; BREAST CANCER; CANCER PREVENTION; CANCER SURGERY; CONTROLLED STUDY; DEPRESSION; DISTRESS SYNDROME; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; SEXUAL FUNCTION; ADULT; GENETIC SCREENING; HETEROZYGOTE DETECTION; MASTECTOMY; MIDDLE AGED; MUTATION; RISK FACTOR; SEXUAL BEHAVIOR; TIME; TUMOR SUPPRESSOR GENE;

ADULT; ANXIETY; BODY IMAGE; DEPRESSION; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HETEROZYGOTE DETECTION; HUMANS; MASTECTOMY; MIDDLE AGED; MUTATION; RISK FACTORS; SEXUAL BEHAVIOR; TIME FACTORS;

EID: 0142119267     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.10.100     Document Type: Article

References (47)

1. Easton DF, Ford D, Bishop DT: Breast and ovarian cancer incidence in BRCA1-mutation carriers: Breast Cancer Linkage Consortium. Am J Hum Genet 56:265-271, 1995
2. Ford D, Easton DF, Stratton M, et al: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families: The Breast Cancer Linkage Consortium. Am J Hum Genet 62:676-689, 1998
3. Antoniou A, Pharoah PD, Narod S, et al: Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies. Am J Hum Genet 72:1117-1130, 2003
4. Meijers-Heijboer EJ, Verhoog LC, Brekelmans CT, et al: Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet 355:2015-2020, 2000
5. Lerman C, Narod S, Schulman K, et al: BRCA1 testing in families with hereditary breast-ovarian cancer: A prospective study of patient decision making and outcomes. JAMA 275:1885-1892, 1996
6. Croyle RT, Smith KR, Botkin JR, et al: Psychological response to BRCA1 mutation testing: Preliminary findings. Health Psychol 16:63-72, 1997
7. Hopwood P, Keeling F, Long A, et al: Psychological support needs for women at high genetic risk of breast cancer: Some preliminary indicators. Psychooncology 7:402-412, 1998
8. Schwartz MD, Peshkin BN, Hughes C, et al: Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. J Clin Oncol 20:514-520, 2002
9. Coyne JC, Benazon NR, Gaba CG, et al: Distress and psychiatric morbidity among women from high-risk breast and ovarian cancer families. J Consult Clin Psychol 68:864-874, 2000
10. Lodder LN, Frets PG, Trijsburg W, et al: Psychological impact of receiving a BRCA1/BRCA2 test result. Am J Med Genet 98:15-24, 2001
11. Lodder LN, Frets PG, Trijsburg RW, et al: One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: Emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery). Breast Cancer Res Treat 73:97-112, 2002
12. Meiser B, Butow P, Friedlander M, et al: Psychological impact of genetic testing in women from high-risk breast cancer families. Eur J Cancer 38:2025-2031, 2002
13. Lodder LN, Frets PG, Trijsburg RW, et al: Presymptomatic testing for BRCA1 and BRCA2: How distressing are the pre-test weeks? J Med Genet 36:906-913, 1999
14. Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361-370, 1983
15. Spinhoven P, Ormel J, Sloekers PP, et al: A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 27:363-370, 1997
16. Horowitz M, Wilner N, Alvarez W: Impact of Event Scale: A measure of subjective stress. Psychosom Med 41:209-218, 1979
17. Lerman C, Trock B, Rimer BK, et al: Psychological side effects of breast cancer screening. Health Psychol 10:259-267, 1991
18. Lerman C, Trock B, Rimer BK, et al: Psychological and behavioral implications of abnormal mammograms. Ann Intern Med 114:657-661, 1991
19. Herrmann C: International experiences with the Hospital Anxiety and Depression Scale: A review of validation data and clinical results. J Psychosom Res 42:17-41, 1997
20. Thewes B, Meiser B, Hickie IB: Psychometric properties of the Impact of Event Scale amongst women at increased risk for hereditary breast cancer. Psychooncology 10:459-468, 2001
21. Joseph S: Psychometric evaluation of Horowitz's Impact of Event Scale: A review. J Trauma Stress 13:101-113, 2000
22. Hopwood P, Shenton A, Lalloo F, et al: Risk perception and cancer worry: An exploratory study of the impact of genetic risk counseling in women with a family history of breast cancer. J Med Genet 38:139-142, 2001
23. Cull AM: The assessment of sexual function in cancer patients. Eur J Cancer 10:1680-1686, 1992
24. Hopwood P: The assessment of body image in cancer patients. Eur J Cancer 2:276-281, 1993
25. Mesters I, van den Borne H, McCormick L, et al: Openness to discuss cancer in the nuclear family: Scale, development, and validation. Psychosom Med 59:269-279, 1997
26. Dudok de Wit AC, Tibben A, Duivenvoorden HJ, et al: Predicting adaptation to presymptomatic DNA testing for late onset disorders: Who will experience distress? Rotterdam Leiden Genetics Workgroup. J Med Genet 35:745-754, 1998
27. Broadstock M, Michie S, Marteau T: Psychological consequences of predictive genetic testing: A systematic review. Eur J Hum Genet 8:731-738, 2000
28. Wellish DK, Gritz ER, Schain W, et al: Psychological functioning of daughters of breast cancer patients. Psychosomatics 33:171-179, 1992
29. Fanos JH: Developmental tasks of childhood and adolescence: Implications for genetic testing. Am J Med Genet 71:22-28, 1997
30. McConkie-Rosell A, DeVellis BM: Threat to parental role: A possible mechanism of altered self-concept related to carrier knowledge. J Genet Couns 9:285-302, 2000
31. Tercyak KP, Streisand R, Peshkin BN, et al: Psychosocial impact of predictive testing for illness on children and families: Challenges for a new millennium. J Clin Psychol Med Settings 7:55-68, 2000
32. Hopwood P: Breast cancer risk perception: What do we know and understand? Breast Cancer Res 2:387-391, 2000
33. Chalmers KKT: Coming to terms with the risk of Breast Cancer: Perceptions of women with primary relatives with breast cancer. Qual Health Res 6:256-282, 1996
34. Tibben A, Duivenvoorden HJ, Niermeijer MF, et al: Psychological effects of presymptomatic DNA testing for Huntington's disease in the Dutch program. Psychosom Med 56:526-532, 1994
35. Vernon SW, Perz CA, Gritz ER, et al: Correlates of psychological distress in colorectal cancer patients undergoing genetic testing for hereditary colon cancer. Health Psychol 16:73-86, 1997
36. Coyne JC, Anderson KK: Marital status, marital satisfaction, and support processes among women at high risk for breast cancer. J Fam Psychol 13:629-641, 1999
37. Wylie JE, Smith KR, Botkin JR: Effects of spouses on distress experienced by BRCA1 mutation carriers over time. Am J Med Genet 119:35-44, 2003
38. Stefanek ME, Helzlsouer KJ, Wilcox PM, et al: Predictors of and satisfaction with bilateral prophylactic mastectomy. Prev Med 24:412-419, 1995
39. Hopwood P, Lee A, Shenton A, et al: Clinical follow-up after bilateral risk reducing ('prophylactic') mastectomy: Mental health and body image outcomes. Psychooncology 9:462-472, 2000
40. Frost MH, Schaid DJ, Sellers TA, et al: Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA 284:319-324, 2000
41. Hatcher MB, Fallowfield L, A'Hern R: The psychosocial impact of bilateral prophylactic mastectomy: Prospective study using questionnaires and semistructured interviews. BMJ 322:1-7, 2001
42. Tiller K, Meiser B, Butow P, et al: Psychological impact of prophylactic oophorectomy in women at increased risk of developing ovarian cancer: A prospective study. Gynecol Oncol 86:212-219, 2002
43. Festinger L: A theory of cognitive dissonance. Stanford, CA, Stanford University Press, 1957
44. Julian-Reynier CM, Bouchard LJ, Evans DG, et al: Women's attitudes toward preventive strategies for hereditary breast or ovarian carcinoma differ from one country to another. Cancer 92:959-968, 2001
45. Lloyd SM, Watson M, Oaker G, et al: Understanding the experience of prophylactic bilateral mastectomy: A qualitative study of ten women. Psychooncology 9:473-485, 2000
46. Payne DK, Biggs C, Tran KN, et al: Women's regrets after bilateral prophylactic mastectomy. Ann Surg Oncol 7:150-154, 2000
47. Lodder L, Frets PG, Trijsburg RW, et al: Attitudes and distress levels in women at risk to carry a BRCA1/BRCA2 gene mutation who decline genetic testing. Am J Med Genet 119A:266-272, 2003